Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 25, 2024, the Compensation Committee (the "Compensation Committee") of the Board of Directors of Intelligent Bio Solutions Inc. (the "Company") granted Harry Simeonidis, the Company's Chief Executive Officer, a special one-time award of 40,000 shares of fully vested common stock, and granted Spiro Sakiris, the Company's Chief Financial Officer, a special one-time award of 34,500 shares of fully vested common stock. The awards to Messrs. Simeonidis and Sakiris were valued at $76,400 and $65,895, respectively, based on the closing price of the Company's common stock on September 25, 2024.

The awards to Messrs. Simeonidis and Sakiris were made in connection with the Company's 2024 compensation analysis and evaluation. The Compensation Committee is composed entirely of independent directors.